Press Releases

Researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with colleagues in France and Germany, have developed a model organism from a genetically modified parasitic worm to better study neglected tropical disease.

The George Washington University (GW) Center for Injury Prevention & Control at the GW School of Medicine and Health Sciences (SMHS) launched a public health campaign on TikTok to persuade young drivers in Washington, D.C., to slow down on the road.

Vitamin D may play an important role in the prevention of Type 2 Diabetes, according to an analysis published by researchers at the George Washington University School of Medicine and Health Sciences. 

Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.

As of 2021 it is estimated that world-wide the number of refugees and asylum-seekers is over 31 million. While academics and researchers have been attempting to capture global and domestic attitudes towards these vulnerable groups, many of these studies will report biased findings and influence…

George Washington University (GW) is excited to share that it launched its chapter of the National Academy of Inventors (NAI) on the 26th of April, 2023. The NAI is an esteemed organization that honors academic inventors and acknowledges the impact of their groundbreaking discoveries on society,…

A new combination drug treatment showed promising results in patients with pan-refractory, recurrent/metastatic head and neck cancer, according to a study published today in the Journal of Clinical Oncology.

The Office of International Medicine Programs (IMP) at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) has just initiated a six-year contract with Ibn Sina University for Medical Sciences (ISUMS), the first private medical school in Amman, Jordan.

Mohamad Koubeissi, MD, FAAN, FANA, FAES, professor of neurology, has been selected to serve as interim chair of the Department of Neurology and Rehabilitation Medicine. Out-going Department Chair Henry Kaminski, MD, will continue to serve the academic medical enterprise in several missions.

A pair of Phase III trials led by Jonathan I. Silverberg, MD, PhD, suggest a 16-week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis. The study results were published in the March 15 edition of the New England Journal of Medicine.